Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway

Anne‐Marie Madec; Roméo Cassel; Séverine Dubois; Sylvie Ducreux; Guillaume Vial; Marie‐Agnès Chauvin; Aurélia Mesnier; Karim Chikh; Domenico Bosco; Jennifer Rieusset; Fabien Van Coppenolle; Charles Thivolet

The FASEB Journal (2013) - Comments
doi: 10.1096/fj.13-234104 issn: 0892-6638 issn: 1530-6860 pubmed: 24008754

Anne‐Marie Madec, Roméo Cassel, Séverine Dubois, Sylvie Ducreux, Guillaume Vial, Marie‐Agnès Chauvin, Aurélia Mesnier, Karim Chikh, Domenico Bosco, Jennifer Rieusset, Fabien Van Coppenolle, Charles Thivolet